Active Surveillance
March 4, 2024
When the cancer is not causing significant health problems or bothersome symptoms and treatment is not yet needed
When the cancer is not causing significant health problems or bothersome symptoms and treatment is not yet needed
Regular blood testing for those with CLL and SLL is an important part of managing the disease, as it can provide valuable insights into your overall health.
Unlike chemoimmunotherapy, new oral therapies don’t increase the risk of other cancers versus active surveillance in CLL patients.
Taking vitamin D supplements during “watch and wait” (a.k.a. active surveillance) was associated with longer treatment-free survival in early-stage CLL.
Clinician Resource Library: Informational Handouts Click below on each of the topical handouts to view and print copies on demand. You may also order a free Welcome Kit which includes a
An ongoing phase 2 clinical trial is studying whether preemptive acalabrutinib plus venetoclax can prevent infections in newly diagnosed CLL patients.
CLL Society awarded Dr. Nancy Musoke a research grant for his project on Curcumin, Exercise and Placebo Effects on CLL / SLL Progression and Immune Function.
June 2025 CLL Bloodline: The CLL Society Bloodline will teach the BASICS needed to understand CLL.
Taking vitamin D during watch and wait extended treatment-free survival from 84 to 169 months in all chronic lymphocytic leukemia (CLL) patients.